Search Results - "Adams, Hugo Ja"

Value of detecting bone marrow involvement in Hodgkin lymphoma by Adams, Hugo J.A., Kwee, Thomas C.

Get full text

Systematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patients by Adams, Hugo J.A., Kwee, Thomas C.

“…This study aimed to systematically review the value of end-of-treatment 18 F-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) in improving…”
Get full text

FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis by Adams, Hugo J. A., Kwee, Thomas C., de Keizer, Bart, Fijnheer, Rob, de Klerk, John M. H., Nievelstein, Rutger A. J.

“…Purpose To systematically review and meta-analyse published data on the diagnostic performance of 18 F-FDG PET/CT in detecting bone marrow involvement in…”
Get full text

Hodgkin lymphoma: is there really a need for interim and end‐of‐treatment FDG‐PET evaluations? by Adams, Hugo J.A., Kwee, Thomas C.

Get full text

Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma by Adams, Hugo J.A, Kwee, Thomas C, Johnson, Peter, Trotman, Judith, Federico, Massimo

“…To the Editor: Johnson et al. (June 23 issue) 1 report that their trial included 172 patients with advanced-stage Hodgkin’s lymphoma who switched from…”
Get full text

Diagnostic value of MRI signs in differentiating Ewing sarcoma from osteomyelitis by Kasalak, Ömer, Overbosch, Jelle, Adams, Hugo Ja, Dammann, Amelie, Dierckx, Rudi Ajo, Jutte, Paul C, Kwee, Thomas C

“…The value of magnetic resonance imaging (MRI) signs in differentiating Ewing sarcoma from osteomyelitis has not be thoroughly investigated. To investigate the…”
Get more information

Assessing baseline bone marrow status in advanced-stage Hodgkin lymphoma: does it have any purpose? by Adams, Hugo J.A., Kwee, Thomas C.

Get full text

Serious concerns on the inability of FDG-PET in excluding residual viable lymphoma by Adams, Hugo J.A., Kwee, Thomas C.

Get full text

Increased bone marrow FDG uptake at PET/CT is not a sufficient proof of bone marrow involvement in diffuse large B‐cell lymphoma by Adams, Hugo J.A., Kwee, Thomas C.

Get full text

Is FDG‐PET/CT a sensitive and specific method for the detection of extranodal involvement in diffuse large B‐cell lymphoma? by Adams, Hugo J.A., Kwee, Thomas C.

Get full text

Malignancy rate of biopsied suspicious bone lesions identified on FDG PET/CT by Adams, Hugo J. A., de Klerk, John M. H., Heggelman, Ben G. F., Dubois, Stefan V., Kwee, Thomas C.

“…Purpose To determine the malignancy rate of bone lesions identified on FDG PET/CT in patients who have undergone CT-guided biopsy because of the suspicion of…”
Get full text

Critical considerations on the utility of 18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography/computed tomography for posttreatment restaging of the bone marrow in diffuse large B‐cell lymphoma by Adams, Hugo J.A., Kwee, Thomas C.

Get full text

Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsy by Adams, Hugo J.A., Kwee, Thomas C., Lokhorst, Henk M., Westerweel, Peter E., Fijnheer, Rob, Kersten, Marie José, Verkooijen, Helena M., Stoker, Jaap, Nievelstein, Rutger A.J.

“…Purpose To assess the prognostic implications of whole‐body bone marrow MRI findings in diffuse large B‐cell lymphoma (DLBCL) patients with a negative blind…”
Get full text

Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise? by Adams, Hugo J A, Kwee, Thomas C, Fijnheer, Rob, Dubois, Stefan V, Nievelstein, Rutger A J, de Klerk, John M H

“…Detection of bone marrow involvement using 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG-PET/CT) has been proposed as a…”
Get more information

Where Does Diffuse Large B-Cell Lymphoma Relapse? by Adams, Hugo J A, de Klerk, John M H, Fijnheer, Rob, Heggelman, Ben G F, Dubois, Stefan V, Nievelstein, Rutger A J, Kwee, Thomas C

“…This study aimed to investigate the anatomic pattern of disease spread at first disease relapse compared with baseline in diffuse large B-cell lymphoma…”
Get full text

Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects by Adams, Hugo Ja, de Klerk, John Mh, Fijnheer, Rob, Heggelman, Ben Gf, Dubois, Stefan V, Nievelstein, Rutger Aj, Kwee, Thomas C

“…There is a lack of data on the effect of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy on brain glucose metabolism of…”
Get more information

Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG‐PET by Adams, Hugo J.A., de Klerk, John M.H., Fijnheer, Rob, Dubois, Stefan V., Nievelstein, Rutger A.J., Kwee, Thomas C.

Get full text

False‐negative FDG‐PET in histologically proven extensive large cell bone marrow involvement in diffuse large B‐cell lymphoma by Adams, Hugo J.A., de Klerk, John M.H., Fijnheer, Rob, Dubois, Stefan V., Nievelstein, Rutger A.J., Kwee, Thomas C.

Get full text

Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value? by Adams, Hugo J A, de Klerk, John M H, Fijnheer, Rob, Heggelman, Ben G F, Dubois, Stefan V, Nievelstein, Rutger A J, Kwee, Thomas C

“…This study aimed to determine the prognostic value of residual anatomical disease, including its size and reduction relative to baseline, in diffuse large…”
Get full text

Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match? by Adams, Hugo J. A., Kwee, Thomas C., Fijnheer, Rob, Dubois, Steven V., Nievelstein, Rutger A. J., de Klerk, John M. H.

“…Purpose To directly compare visual and quantitative 18 F-fluoro-2-deoxy- d -glucose positron emission tomography/computed tomography (FDG-PET/CT) to bone…”
Get full text